CYRUSONE INC's ticker is CONE and the CUSIP is 23283R100. A total of 431 filers reported holding CYRUSONE INC in Q3 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $4,486,000 | +15.9% | 50,000 | 0.0% | 0.07% | +6.2% |
Q3 2021 | $3,871,000 | +8.2% | 50,000 | 0.0% | 0.06% | +4.9% |
Q2 2021 | $3,576,000 | +5.6% | 50,000 | 0.0% | 0.06% | -7.6% |
Q1 2021 | $3,386,000 | -7.4% | 50,000 | 0.0% | 0.07% | -13.2% |
Q4 2020 | $3,658,000 | +4.5% | 50,000 | 0.0% | 0.08% | -17.4% |
Q3 2020 | $3,502,000 | -3.7% | 50,000 | 0.0% | 0.09% | -16.4% |
Q2 2020 | $3,638,000 | +17.8% | 50,000 | 0.0% | 0.11% | -2.7% |
Q1 2020 | $3,088,000 | -62.5% | 50,000 | -60.3% | 0.11% | -56.0% |
Q4 2019 | $8,239,000 | -91.2% | 125,928 | -89.3% | 0.26% | -90.0% |
Q3 2019 | $93,455,000 | -11.4% | 1,181,485 | -35.4% | 2.57% | -4.7% |
Q2 2019 | $105,533,000 | -5.0% | 1,828,362 | -13.7% | 2.70% | +23.3% |
Q1 2019 | $111,081,000 | -5.9% | 2,118,258 | -5.1% | 2.19% | -22.3% |
Q4 2018 | $118,001,000 | +15.8% | 2,231,493 | +38.8% | 2.82% | +42.3% |
Q3 2018 | $101,905,000 | +64.9% | 1,607,334 | +51.8% | 1.98% | +38.9% |
Q2 2018 | $61,815,000 | +24.1% | 1,059,196 | +8.9% | 1.42% | +40.1% |
Q1 2018 | $49,802,000 | +7.5% | 972,511 | +25.0% | 1.02% | -15.3% |
Q4 2017 | $46,313,000 | – | 777,977 | – | 1.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRS Advisors, LLC | 518,000 | $28,832,000 | 8.05% |
Barings Real Estate Advisers LLC | 283,326 | $15,770,000 | 5.21% |
American Assets Capital Advisers, LLC | 140,000 | $7,792,000 | 5.01% |
Land & Buildings Investment Management | 158,300 | $8,811,000 | 4.77% |
Riggs Asset Managment Co. Inc. | 137,928 | $7,677,000 | 4.03% |
SEVEN LOCKS CAPITAL MANAGEMENT LP | 107,415 | $5,979,000 | 3.26% |
CROSSLINK CAPITAL INC | 302,853 | $16,857,000 | 3.03% |
Waterfront Capital Partners, LLC | 328,283 | $18,272,000 | 2.91% |
Friedberg Investment Management | 107,750 | $5,997,000 | 2.83% |
CAPITAL GROWTH MANAGEMENT LP | 1,025,000 | $57,052,000 | 2.54% |